Dawei Chen
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Fc-dependent and -independent Platelet Clearance Caused by Anti-CD36 IgG1 and IgG2 Subclasses.
Journal: Thrombosis and haemostasis
Published: January 29, 2026
Synergistic effects between CD36 monoclonal antibody and cytarabine for treatment of AML.
Journal: European journal of pharmacology
Published: September 17, 2025
Antibody-Mediated In Vitro Activation and Expansion of Blood Donor-Derived Natural Killer Cells with Transient Anti-Tumor Efficacy.
Journal: Biomedicines
Published: September 09, 2025
Pharmacovigilance Signal for ILD Reporting with Magnesium Oxide and Immunoradiotherapy in NSCLC: An Observational Study.
Journal: Archivos de bronconeumologia
Published: May 09, 2025
Preparation and preliminary identification of Fc-silent anti-human CD36 chimeric antibody
Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
Published: October 23, 2024
Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy.
Journal: Pharmacological research
Published: April 25, 2024
Synthesis and Anti-Influenza Virus Effects of Novel Substituted Polycyclic Pyridone Derivatives Modified from Baloxavir.
Journal: Journal of medicinal chemistry
Published: September 22, 2021
Discovery of 2-(1-(3-(4-Chloroxyphenyl)-3-oxo- propyl)pyrrolidine-3-yl)-1H-benzo[d]imidazole-4-carboxamide: A Potent Poly(ADP-ribose) Polymerase (PARP) Inhibitor for Treatment of Cancer.
Journal: Molecules (Basel, Switzerland)
Published: March 14, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026